ArticleThe oncologist2017

Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.

Joshua A Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.